Antisoma selects renal cancer and melanoma as phase I indications for AS1409
Antisoma selects renal cancer and melanoma as phase I indications for AS1409
London, UK: 29 August 2006 - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its forthcoming phase I trial of AS1409 will enrol patients with renal cancer and melanoma. High levels of the drug’s target are found in these cancers.
Facial Resurfacing Treats Precancerous Skin Lesions, May Help Prevent Skin Cancer
A program that helps parents talk to their children about skin cancer risks may promote sun-safe behaviors, especially when parents and children have a high-quality relationship, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journals. [click link for full article]
Mohs Surgery for Skin Cancer
Summer time comes and goes. But, it certainly can leave it’s mark on your skin… Each year the sun kills 60-thousand people, mostly from malignant skin cancer. That’s why, even here in North Dakota, skin doctors are in high demand… (David App